Your browser doesn't support javascript.
loading
Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control study.
Abdi, Amal; Eckhardt, Corien L; van Velzen, Alice S; Vuong, Caroline; Coppens, Michiel; Castaman, Giancarlo; Hart, Dan P; Hermans, Cedric; Laros-van Gorkom, Britta; Leebeek, Frank W G; Mancuso, Maria Elisa; Mazzucconi, Maria G; McRae, Simon; Oldenburg, Johannes; Male, Christoph; van der Bom, Johanna G; Fijnvandraat, Karin; Gouw, Samantha C.
Afiliação
  • Abdi A; Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Eckhardt CL; Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • van Velzen AS; Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Vuong C; Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Coppens M; Vascular Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Castaman G; Oncology, Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy.
  • Hart DP; Barts and The London School of Medicine and Dentistry, The Royal London Hospital Haemophilia Centre, QMUL, London, UK.
  • Hermans C; Haemostasis and Thrombosis Unit, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Laros-van Gorkom B; Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Leebeek FWG; Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Mancuso ME; Center for Thrombosis and Hemorrhagic Diseases, Humanitas Clinical and Research Center, Rozzano, Italy.
  • Mazzucconi MG; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • McRae S; Hematology, Sapienza University of Rome, Rome, Italy.
  • Oldenburg J; Hematology, Launceston General Hospital, Launceston, Tasmania, Australia.
  • Male C; Institute of Experimental Haematology and Transfusion Medicine Bonn, University Clinic Bonn, Bonn, Germany.
  • van der Bom JG; Paediatrics, Medical University of Vienna, Vienna, Austria.
  • Fijnvandraat K; Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Gouw SC; Center for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands.
J Thromb Haemost ; 19(9): 2171-2181, 2021 09.
Article em En | MEDLINE | ID: mdl-34107158
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemostáticos / Hemofilia A Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemostáticos / Hemofilia A Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article